94 related articles for article (PubMed ID: 18813817)
1. An unusual p53 mutation detected in Burkitt's lymphoma: 30 bp duplication.
Smardova J; Grochova D; Fabian P; Moulis M; Smarda J; Falkova I; Ravcukova B; Vankova J; Vasova I
Oncol Rep; 2008 Oct; 20(4):773-8. PubMed ID: 18813817
[TBL] [Abstract][Full Text] [Related]
2. Increased rate of transcription contributes to elevated expression of the mutant p53 gene in Burkitt's lymphoma cells.
Bálint E; Reisman D
Cancer Res; 1996 Apr; 56(7):1648-53. PubMed ID: 8603415
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations in Raji cells: characterization and localization relative to other Burkitt's lymphomas.
Duthu A; Debuire B; Romano J; Ehrhart JC; Fiscella M; May E; Appella E; May P
Oncogene; 1992 Nov; 7(11):2161-7. PubMed ID: 1437144
[TBL] [Abstract][Full Text] [Related]
4. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.
Bhatia KG; Gutiérrez MI; Huppi K; Siwarski D; Magrath IT
Cancer Res; 1992 Aug; 52(15):4273-6. PubMed ID: 1638540
[TBL] [Abstract][Full Text] [Related]
5. A human Burkitt's lymphoma cell line carrying t(8;22) and t(14;18) translocations.
Kiefer T; Schüler F; Knopp A; Wimmer M; Hirt C; Schaefer HE; Dölken G
Ann Hematol; 2007 Nov; 86(11):821-30. PubMed ID: 17622530
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719
[TBL] [Abstract][Full Text] [Related]
7. Dok1 expression and mutation in Burkitt's lymphoma cell lines.
Lee S; Huang H; Niu Y; Tommasino M; Lenoir G; Sylla BS
Cancer Lett; 2007 Jan; 245(1-2):44-50. PubMed ID: 16338067
[TBL] [Abstract][Full Text] [Related]
8. [Interphase FISH analysis on histologic sections of fixed tissues for t(11;14) (q13;q32) detection in mantle cell lymphoma and t(8;14)(q24;q32) in Burkitt's lymphoma].
Belaud-Rotureau MA; Parrens M; Dubus P; Turmo M; Lacroute G; Taine L; Vago P; De Mascarel A; Merlio JP
Ann Pathol; 2002 Apr; 22(2):145-9. PubMed ID: 12124502
[TBL] [Abstract][Full Text] [Related]
9. Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells.
Cherney BW; Bhatia KG; Sgadari C; Gutierrez MI; Mostowski H; Pike SE; Gupta G; Magrath IT; Tosato G
Cancer Res; 1997 Jun; 57(12):2508-15. PubMed ID: 9192833
[TBL] [Abstract][Full Text] [Related]
10. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
Smardová J; Pavlová S; Svitáková M; Grochová D; Ravcuková B
Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349
[TBL] [Abstract][Full Text] [Related]
11. [Detection of translocations diagnostic for Berkitt's lymphoma by fluorescent in situ hybridization on histological sections of paraffin blocks].
Obukhova TN; Bariakh EA; Kaplanskaia IB; Domracheva EB; Kravchenko SK
Ter Arkh; 2007; 79(7):80-3. PubMed ID: 17802797
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of p53 tumor suppressor in yeast.
Smardová J; Smarda J; Koptíková J
Differentiation; 2005 Jul; 73(6):261-77. PubMed ID: 16138827
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
Preudhomme C; Dervite I; Wattel E; Vanrumbeke M; Flactif M; Lai JL; Hecquet B; Coppin MC; Nelken B; Gosselin B
J Clin Oncol; 1995 Apr; 13(4):812-20. PubMed ID: 7707106
[TBL] [Abstract][Full Text] [Related]
14. [The cytogenetic features of Burkitt leukemia].
Xie X; Xu W; Qiu H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):214-7. PubMed ID: 18393250
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
[TBL] [Abstract][Full Text] [Related]
16. Identification of a transcriptionally inactive p53 mutant by functional analysis of separated alleles in yeasts (FASAY) in a child osteosarcoma tumor: a case report.
Dekairelle AF; Brichard B; Delhez H; Gala JL
Pediatr Hematol Oncol; 2004 Jun; 21(4):321-8. PubMed ID: 15205094
[TBL] [Abstract][Full Text] [Related]
17. Gene-hypermutated isoforms of MYC protein: Tumour-suppressor P-53 protective-initiation of apoptosis that normally prevents Burkitt's lymphoma tumorigenesis can be enhanced.
Wiseman A
Med Hypotheses; 2006; 66(5):1046-7. PubMed ID: 16413684
[No Abstract] [Full Text] [Related]
18. Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.
Kamihira S; Terada C; Sasaki D; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y
Eur J Haematol; 2009 Apr; 82(4):301-7. PubMed ID: 19220422
[TBL] [Abstract][Full Text] [Related]
19. p53 is frequently mutated in Burkitt's lymphoma cell lines.
Farrell PJ; Allan GJ; Shanahan F; Vousden KH; Crook T
EMBO J; 1991 Oct; 10(10):2879-87. PubMed ID: 1915267
[TBL] [Abstract][Full Text] [Related]
20. [P53 genes and malignant hematologic diseases].
Jonveaux P
Bull Cancer; 1993 Aug; 80(8):697-703. PubMed ID: 8204951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
